| 发明名称 |
Hybridoma Clones, Monoclonal Antibodies, and Methods of Use |
| 摘要 |
The present invention is directed to a monoclonal antibody that recognizes human CD63 in its native form. The invention is also directed to a hybridoma cell line that produces the monoclonal antibody, and to methods of diagnosing and treating cancer and purifying exosomes using the antibody. The invention is further directed to pharmaceutical compositions comprising an antibody of the invention and a pharmaceutically acceptable carrier. |
| 申请公布号 |
US2016115229(A1) |
申请公布日期 |
2016.04.28 |
| 申请号 |
US201314890317 |
申请日期 |
2013.05.15 |
| 申请人 |
AZORSA David;THE TRANSLATIONAL GENOMICS RESEARCH INSTITUTE |
发明人 |
Azorsa David |
| 分类号 |
C07K16/28;C07K16/30;G01N33/574 |
主分类号 |
C07K16/28 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. An isolated antibody that binds to a human CD63 protein, wherein the antibody is produced by a hybridoma cell line having ATCC accession number PTA-120178 and the antibody recognizes a CD63 protein from at least one colon cancer cell line. |
| 地址 |
Scottsdale AZ US |
